论文信息 - Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain. - 字舞流文

Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain.

J. Garcia-conde | A. Lluch | V. Guillem | A. Llombart-Cussac | V. Carañana | A. Barnadas | R. Colomer | B. Ojeda | J. Hornedo | S. Montero | Y. Fernández | S. Alonso